Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VRDN · against 1,335 other Healthcare companies
Ranked #1,236 of 1,336 · scores higher than 7% of peers
Bars: peers in each 10-point band of the profitability score127 peers with a profitability score of 0–9, including VRDN · Click a bar to see the companies
Mainly because of its operating margin, return on assets and return on invested capital, which are weaker than most Healthcare peers.
| Metric | VRDN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 1,226 reported | -61.8% | 4.7% | 11% | 33% | |
| Operating marginHigher is better · 1,251 reported | -569.7% | 7.1% | 7% | 33% | |
| Return on assetsHigher is better · 1,315 reported | -35.3% | 1.7% | 11% | 33% | |
| Return on equityHigher is better · 1,252 reported | -65.7% | 3.2% | 11% | Context only | |
| Gross marginHigher is better · 1,394 reported | 0.0% | 45.9% | 3% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 1,236 | 1.1B USD | 7 | 50 | |
| 1,236 | 649M SEK (≈$65M) | 7 | 29 | |
| 1,236 | 2.4B USD | 7 | 20 | |
| 1,236 | 158M USD | 7 | 14 | |
| 1,236 | 2.8B USD | 7 | 51 | |
| 1,236 | 113M USD | 7 | 23 | |
| 1,236 | 705M USD | 7 | 32 | |
| 1,250 | 13.0B TWD (≈$402M) | 6 | 49 | |
| 1,250 | 1.1B HKD (≈$141M) | 6 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score